12:00 AM
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Adamas Pharmaceuticals preclinical data

In a rat model of TBI, once-daily 45 and 135 mg/kg Nurelin initiated 1 hour post-TBI and continued for 16 days each significantly improved overall performance as measured by latency to find a hidden platform in the Morris Water Maze...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >